This past Friday, the Altamira Therapeutics Ltd (NASDAQ:CYTO) stock had emerged as one of the stocks to have come into sharp focus among investors and ended the day with gains of as much as 8% as a consequence.
While the gains made by the Altamira stock are eye catching, investors need to keep in mind that there was no news about the company on Friday. In this sort of a situation, it might be a good idea for investors to perhaps take a look at an update provided by Altamira back on September 27.
The update in question was with regards to its product Bentrio, which is meant for providing protection against allergens and viruses which are air borne. The company noted that the product was launched in Germany first and was solely sold through online channels.
In its update, Altamira stated that the Bentrio.com website managed to attract as many as 2500 visitors from Germany on average on a daily basis. In addition to that, the company also pointed out that it had also expanded promotional activities in stages to other nations in Europe. At this point in time, investors could do well to keep an eye on the latest news with regards to Altamira.
